SILVER SPRING Md. Sept. 23 2011 PRNewswireUSNewswire The U.S. Food and Drug Administration today approved Remicade infliximab to treat moderately to severely active ulcerative colitis UC in children older than 6 years who have had inadequate response to c...
↧